Scientists have apparently discovered new genetic variants in five regions of the genome that affect the risk of ovarian cancer in the general population.
The consortium, including scientists from the U.S., Europe, Canada and Australia, based the new work on their earlier research comparing 10,283 women with ovarian cancer to 13,185 women without the disease.
That effort had found a stretch of DNA on chromosome 9 containing single DNA letter variations (SNPs) associated with ovarian cancer risk.
The researchers have now found additional stretches of DNA on chromosomes 2, 3, 8, 17 and 19 after grouping patients according to the type of ovarian cancer they had developed.
Four out of five of the new DNA variations were more common in women who had developed the most common and aggressive form of disease, known as serous ovarian cancer.
Andrew Berchuck of the Duke University Medical Center and head of the steering committee of the international Ovarian Cancer Association Consortium (OCAC), said the associations of these genetic variants with ovarian cancer were discovered using genome-wide association studies (GWAS).
"Since the critical validation of these findings was performed by a large consortium of investigators from around the world, we see this research as a triumph of science without borders for the benefit of women everywhere," Nature quoted Berchuck as saying.
"These latest findings raise the possibility that in the future, women in the general population who are at the greatest risk of developing ovarian cancer because they carry these newly discovered DNA variants can be identified and given closer surveillance to look for early signs of ovarian cancer when it is most treatable," added Berchuck.
Ellen Goode of the Mayo Clinic College of Medicine said "additional research will be required to learn more about the specific genes and DNA changes in these DNA stretches that could be causing ovarian cancer," but added the newly implicated regions of the genome also contain some familiar suspects.
"What is surprising is that we found that three of the most common SNPs for ovarian cancer lie quite a distance away from this bunch of troublemakers - in an apparent gene desert - which suggests they may be causing functional problems by a very different mechanism," said Goode.
A second study found a region of DNA on chromosome 19 that also affects ovarian cancer risk. And a third study found that variation in this same region of chromosome 19 also increases the risk of breast cancer in women who already carry a faulty copy the BRCA1 gene on chromosome 17.
Researchers have known for some time that heritable mutations in the BRCA1 and BRCA2 genes can dramatically increase a woman''s chances of developing breast and ovarian cancer, but these mutations only account for a small percent of ovarian cancers.
Because DNA variations such as those described in these new studies are much more common in the general population than BRCA1 and BRCA2, researchers concluded that they probably cause a much greater proportion of all ovarian cancers, even though the overall cancer risks associated with these SNPs are smaller.
Simon Gayther of the University of Southern California said: "Our study shows that the same genetic region plays a role in both breast and ovarian cancer, suggesting that the same faulty pathway can cause both diseases, just like BRCA1 and BRCA2 do. This is important because it suggests that women who carry certain versions of this stretch of DNA could benefit from closer monitoring for both breast and ovarian cancers."
The studies appeared in the journal Nature Genetics.
No comments:
Post a Comment